Safety and immunogenicity of the LC16m8 vaccine against mpox during outbreak deployment in Colombia: a hybrid, multicentre, open-label, randomised controlled trial and observational cohort study
Safety and immunogenicity of the LC16m8 vaccine against mpox during outbreak deployment in Colombia: a hybrid, multicentre, open-label, randomised controlled trial and observational cohort study. // eBioMedicine. – URL: https://www.sciencedirect.com/science/article/pii/S2352396426004330?dgcid=rss_sd_all
Safety and immunogenicity of the LC16m8 vaccine against mpox during outbreak deployment in Colombia: a hybrid, multicentre, open-label, randomised controlled trial and observational cohort study. eBioMedicine. https://www.sciencedirect.com/science/article/pii/S2352396426004330?dgcid=rss_sd_all
“Safety and immunogenicity of the LC16m8 vaccine against mpox during outbreak deployment in Colombia: a hybrid, multicentre, open-label, randomised controlled trial and observational cohort study.” eBioMedicine.
@article{article43612,
title = {Safety and immunogenicity of the LC16m8 vaccine against mpox during outbreak deployment in Colombia: a hybrid, multicentre, open-label, randomised controlled trial and observational cohort study},
journal = {eBioMedicine},
url = {https://www.sciencedirect.com/science/article/pii/S2352396426004330?dgcid=rss_sd_all}
}